Glutamate antagonism fails to reverse mitochondrial dysfunction in late phase of experimental neonatal asphyxia in rats

Neurochemistry International

Volumn 58, Issue 5, 2011, Pages 582-590

  Reddy, Nagannathahalli Ranga ^a   Krishnamurthy, Sairam ^a   Chourasia, Tapan Kumar ^b   Kumar, Ashok ^c   Joy, Keerikkattil Paily ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c BANARAS HINDU UNIVERSITY   (India)

Author keywords

Anoxia; Glutamate; Ketamine; Mitochondrial function; Nitric oxide

Indexed keywords

GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; KETAMINE; MALONALDEHYDE; NITRIC OXIDE; RHODAMINE; SUCCINATE DEHYDROGENASE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; ARTICLE; BRAIN CORTEX; BRAIN REGION; CELL DEATH; CEREBELLUM; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEWBORN HYPOXIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; ASPHYXIA; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; KETAMINE; MITOCHONDRIA; OXIDATIVE STRESS; PREGNANCY; RATS; TIME FACTORS;

RATTUS;

EID: 79952575067     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.01.021     Document Type: Article

References (94)

1. Akihito, N., Yukino, S., Yoshinari, T., Hidehiko, M., Atsuko, O., Toshiyuki, T., 2004. Role of mitochondrial permeability transition in fetal brain damage in rats. Pediatr. Neurol. 30, 247-253.
2. Alejandro, F.S., Eric, C.O., Nicholas, C.S., Mauricio, M., 1996. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16, 6125-6133.
3. Alistair, J.G., Peter, D.G., 1998. Pharmacological strategies for the prevention of perinatal brain damage. Semin. Neonatol. 3, 87-101.
4. Alkan, T., Kahveci, N., Buyukuysal, L., Korfali, E., Ozluk, K., 2001. Neuroprotective effects of MK 801 and hypothermia used alone and in combination in hypoxic - ischemic brain injury in neonatal rats. Arch Physiol. Biochem. 109, 135-144.
5. Angeles, A., Simon, J.R.H., Juan, P.B., Jose, M.M., 1998. Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion. Brain Res. 790, 209-216.
6. Anna, A., Pietro, C., Antonella, B., Amalia, A., Ersilia, M., Salvatore, P., 2000. Cytochrome-C is released from mitochondria in a ROS dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic death. J. Biol. Chem. 275, 37159-37166.
7. Atlante, A., Gagliardi, S., Minervini, G.M., Ciotti, M.T., Marra, E., Calissano, P., 1997. Glutamate neurotoxicity in rat cerebellar granule cells: a major role for xanthine oxidase in oxygen radical formation. J. Neurochem. 68, 2038-2045. (Pubitemid 27176140)
8. 2 produce reactive oxygen species via mitochondria. Brain Res. 1037, 200-203.
9. Batool, A.H., Zulfiqar, A.B., 2006. Birth asphyxia in developing countries: current status and public health implications. Curr. Probl. Pediatr. Adolesc. Health Care 36, 178-188.
10. Bennet, L., Roelfsema, V., Pathipati, P., Quaedackers, J.S., Gunn, A.J., 2006. Relationship between evolving epileptiform activity and delayed loss of mitochondrial activity after asphyxia measured by near-infrared spectroscopy in preterm fetal sheep. J. Physiol. 572, 141-154.
11. Bernd, S., Elke, P., Josef, K., Jochen, H.M.P., 1998. NMDA-induced superoxide production and neurotoxicity in cultured rat hippocampal neurons: role of mitochondria. Eur. J. Neurosci. 10, 1903-1910.
12. Blomgren, K., Zhu, C., Hallin, U., Hagberg, H., 2003. Mitochondria and ischemic reperfusion damage in the adult and in the developing brain. Biochem. Biophys. Res. Commun. 304, 551-559.
13. Bora, E.B., Wendy, S.R., Peter, E.M.T., 2001. Phenotypic dichotomy in mitochondrial complex II genetic disorders. J. Mol. Med. 79, 495-503.
14. Cacha, P.-S., Johanna, K., Wouter, V., Evelyn, V-D.T., Changlian, Z., Nicole, K., Klas, B., Dop, B., Sylvia, V.B-O., Hendrik, H., Klaas, N., Frank, V.B., Floris, G., 2002. Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia - ischemia. Stroke 33, 2304-2310.
15. Carol, K.P., Jorge, T.-M., Brenda, R., John, -P.O., Thaddeus, S.N., William, A.P., 1997. DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat. J. Cereb. Blood Flow Metab. 17, 967-976.
16. Chen, H.S., Lipton, S.A., 2006. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 97, 1611-1626. (Pubitemid 43873656)
17. Christina, K., Stefan, K., Wilhelm, M., Nicolas, S., Dimitri, K., Helmut, P., Harald, H., Barbara, L., 1999. Histological changes and neurotransmitter levels three months following perinatal asphyxia in the rat. Life Sci. 23, 2109-2124.
18. David, G.N., Samantha, L.B., 1998. Mitochondria and neuronal glutamate excitotoxicity. Biochim. Biophys. Acta 1366, 97-112.
19. Deorari, A.K., Paul, V.K., Singh, M., Vidyasagar, D., 2000. The national movement of neonatal resuscitation in India. J. Trop. Pediatr. 46, 315-317.
20. Dietrich, W.D., Lin, B., Globus, M.Y., Green, E.J., Ginsberg, M.D., Busto, R., 1995. Effect of delayed MK-801 (dizocilpine) treatment with or without immediate post ischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 15, 960-968.
21. Domenico, E.P-G., Fiamma, P., Elena, M., Andrea, C., Serenella, A.-T., Roberto, P., Flavio, M., 1999. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms. Neuropharmacology 38, 1607-1619.
22. Dorota, M., Małgorzata, D., Roman, G., Wojciech, D., Jerzy, W.L., 2006. Neuroprotective potential of group I metabotropic glutamate receptor antagonists in two ischemic models. Neurochem. Int. 48, 485-490.
23. Douglas, L.R., Nicola, R.S., Fahmeed, H., Jun, S., Kevin, L.B., Robert, G.S., 1999. In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 354, 1165-1177.
24. Elisabetta, D.A., Yong, C., Ephrem, E., Kurt, A., Gert, L., Johan, L., Mario, H.-M., 1997. Delayed neuronal death following perinatal asphyxia in rat. Exp. Brain Res. 115, 105-115.
25. Eric, G., Henrik, H., 1997. Is MK-801 neuroprotection mediated by systemic hypothermia in the immature rat? Neuroreport 8, 1603-1605.
26. Evangelia, S., George, K., Vassiliki, S., Persephone, A.-S., Theodoros, L., Olympia, G.-T., 1999. Effect of ketamine on hypoxic-ischemic brain damage in newborn rats. Brain Res. 819, 1-7.
27. Federica, D.-S., Maura, F., Davide, F., Stephen, D.S., Pietro, G., 2001. Kainic acid induces selective mitochondrial oxidative phosphorylation enzyme dysfunction in cerebellar granule neurons: protective effects of melatonin and GSH ethyl ester. FASEB J. 15, 1786-1788.
28. Flint, B.M., 1992. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 6, 3338-3344.
29. Foster, A.C., Gill, R., Woodruff, G.N., 1988. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J. Neurosci. 8, 4745-4754. (Pubitemid 19015157)
30. Francesc, X.S., Elena, E., Cecilia, G., Jorge, C., Antonio, C., 1996. Effect of glutamate receptor ligands on mitochondrial membrane potential in rat dissociated cerebellar cells. Naunyn Schmiedebergs Arch. Pharmacol. 354, 420-423.
31. Gabor, I., Amber, S., Minke, J., Dirk, S.F., Johan, A.D.B., Gert, J.T.H., 2006. Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat. Pharmacol. Biochem. Behav. 84, 392-399.
32. Gabriel, G., Fabrice, P., Boubekeur, S., Cathie, L., 2006. The glutamate - glutamine cycle as an inducible, protective face of macrophage activation. J. Leukoc. Biol. 80, 1067-1075.
33. Gordon, L.R., Anthony, J.F., Jacques, B.B., Geraldine, J.K., Ian, J.R., 2003. Glutamate decreases mitochondrial size and movement in primary forebrain neurons. J. Neurosci. 23, 7881-7888.
34. Gottlieb, E., Armour, S.M., Harris, M.H., Thompson, C.B., 2003. Mitochondrial membrane potential regulates matrix configuration and cytochrome-C release during apoptosis. Cell Death Differ. 10, 709-717. (Pubitemid 36675732)
35. Griess, P., 1879. Bemerkungen zu der abhandlung der H.H. Weselsky und Benedikt. "Ueber einige azoverbindungen" Chem. Ber. 12, 426-428.
36. Guido, K., Lorenzo, G., Catherine, B., 2007. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99-163.
37. Gunn, A.J., Battin, M., Gluckman, P.D., Gunn, T.R., Bennet, L., 2005. Therapeutic hypothermia: from lab to NICU. J. Perinat. Med. 33, 340-346.
38. Henrik, H., 2004. Mitochondrial impairment in the developing brain after hypoxia - ischemia. J. Bioenerg. Biomembr. 36, 369-373.
39. Hori, N., Carpenter, D.O., 1994. Functional and morphological changes induced by transient in vivo ischemia. Exp. Neurol. 129, 279-289.
40. Jacques, O.C., Fabrizio, S., Michael, R., Fayez, F.S., Michael, M.M., Nancy, N.B., Mary, F.B., 2008. Impact of neonatal asphyxia and hind limb immobilization on musculoskeletal tissues and S1 map organization: Implications for cerebral palsy. Exp. Neurol. 210, 95-108.
41. James Jr., B.P, Brian, M.C., 1997. Release of endogenous glutamate and γ-amino butyric acid from rat striatal tissue slices measured by an improved method of high performance liquid chromatography with electrochemical detection. J. Neurosci. Methods 75, 207-214.
42. James, G.G., Timothy, G.J., 1995. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J. Neurochem. 64, 430-436.
43. James, M., 1992. Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. Br. J. Clin. Pharmacol. 34, 106-114.
44. Jeffrey, M.P., 2006. Summary proceedings from the neurology group on hypoxic - ischemic encephalopathy. Pediatrics 117, 28-33.
45. Juan, P.B., Angeles, A., Jose, M.M., 1998. Nitric oxide mediates brain mitochondrial damage during perinatal anoxia. Brain Res. 787, 117-122.
46. Juan, P.B., Angeles, A., Victoria, S., Stephan, P., John, M.L., John, B.C., Simon, J.R.H., 1997. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68, 2227-2240.
47. Julio, F.T., 2003. Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335-344.
48. Jung, Y.Y., Jin, H.K., Hae, K.K., Young, J.L., Sang, H.D., Zhiyi, Z., 2006. Effects of intravenous anesthetics on the activity of glutamate transporter EAAT3 expressed in Xenopus oocytes: evidence for protein kinase C involvement. Eur. J. Pharmacol. 531, 133-139.
49. Kakkar, P., Das, B., Viswanathan, P.N., 1984. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. 21, 130-132.
50. Keith, W.M., 2006. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr. Opin. Pharmacol. 6, 53-60.
51. Kenneth, J.B., Ying, X., Gabriel, G.H., 2000. Mechanisms underlying hypoxia induced neuronal apoptosis. Prog. Neurobiol. 62, 215-249.
52. Kolatat, T., Vanprapar, N., Thitadilok, W., 2000. Perinatal asphyxia: multivariate analysis of risk factors. J. Med. Assoc. Thai. 83, 1039-1044.
53. Laura, M.R., Juan, R.B., Paul, G.M., Rex, E.J., Rhoshel, L., Elma, L., Ranee, B., Ronald, Y., John, L., William, M.B., 2005. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am. J. Psychiatry 162, 394-396.
54. Leighton, P.M., Robert, W.P., John, L.U., Michelle, M.S., David, L.D., James, M.S., Douglas, B.W., Lotfi, H.-B., 2001. Pictorial review of glutamate excitotoxicity-fundamental concepts for neuroimaging. Am. J. Neuroradiol. 22, 1813-1824.
55. Lina, S., Jeffrey, M.P., 2004. Hypoxic - ischemic brain injury in the term infantcurrent concepts. Early Hum. Dev. 80, 125-141.
56. Luca, T.B., Aldina, V., Flavia, C., Enrico, A., Francesca, C., 2006. Acute perinatal asphyxia at birth has long-term effects on behavioral arousal and maternal behavior in lactating rats. Behav. Brain Res. 172, 54-62.
57. Lowry, O.H., Rosenborough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with folin phenol reagent. J. Biol. Chem. 193, 265-275.
58. Maria, A., Jeannette, M.D., Emanuela, B., Boris, Z., Sten, O., Stuart, A.L., Pierluigi, N., 1995. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
59. Michelle, M.A., Michael, T., 2003. Novel treatment of excitotoxicity: targeted disruption of intracellular signaling from glutamate receptors. Biochem. Pharmacol. 66, 877-886.
60. Murata, J., Ikeda, M., Takazawa, A., Kaneko, T., Suzuki, H., 2000. Differential effects of ketamine enantiomers on anesthetic levels and glutamate release in the hippocampus. Masui 49, 255-262. (Pubitemid 30187163)
61. Nickolay, B., Tatiana, B., Ronald, J., Janet, M.D., 2002. Calcium-induced Cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. J. Neurochem. 80, 207-218.
62. Novelli, A., Reilly, J.A., Lysko, P.G., Henneberry, R.C., 1988. Glutamate becomes neurotoxic via NMDA receptors when intracellular energy levels are reduced. Brain Res. 451, 205-212.
63. Pak, H.C., 2001. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21, 2-14.
64. Pedersen, P.L., Grenawalt, J.W., Reynafarje, B., Hullihen, J., Decker, G.L., Soper, J.W., Bustamente, E., 1978. Preparation and characterization of mitochondria and submitochondrial particles of rat liver-derived tissues. Methods Cell Biol. 20, 411-481. (Pubitemid 9018527)
65. Phillisa, J.W., Rena, J., Regan, M.H.O., 2000. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with mDLthreo-b-benzyloxyaspartate. Brain Res. 868, 105-112.
66. Puka-Sundval, M., Gilland, E., Bona, E., Lehmann, A., Sandberg, M., Hagberg, H., 1996. Development of brain damage after neonatal hypoxia-ischemia: excitatory amino acids and cysteine. Metab. Brain Dis. 11, 109-123.
67. Rajiv, A., Ashok, K.D., Vinod, K.P., 2001. Post-resuscitation management of asphyxiated neonates. Indian J. Pediatr. 68, 1149-1153.
68. Robert, L.M., Peter, J.H., 1993. The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. J. Cell Sci. 104, 917-927.
69. Roy, P.M., Stefan, C.D., 2008. Pre and perinatal anoxia and hypoxia. In: Prenatal Exposures. Psychological and Educational Consequences for Children, Springer, New York, pp. 47-54.
70. Ruei, M.C., Ta-L, C., Yi-L, L., Tyng-G, C., Yu-T, T., 2005. Ketamine reduces nitric oxide biosynthesis in human umbilical vein endothelial cells by down-regulating endothelial nitric oxide synthase expression and intracellular calcium levels. Crit. Care Med. 33, 1044-1049.
71. Sabine, H., Ernst, P., Eberhard, K., Martina, A., 2000. S (+)-ketamine up-regulates neuronal regeneration associated proteins following glutamate injury in cultured rat hippocampal neurons. J. Neurosurg. Anesthesiol. 12, 84-94.
72. Sally, L.O., Margaret, A.J., 1989. Methods of micro photometric assay of succinate dehydrogenase and cytochrome-C oxidase activities for use on human skeletal muscle. Histochem. J. 21, 545-555.
73. Shinn, Z.L., Ai-Lin, C., Yun, W., 1996. Ketamine antagonizes nitric oxide release from cerebral cortex after middle cerebral artery ligation in rats. Stroke 27, 747-752.
74. Shu-Gui, H., 2002. Development of a high throughput screening assay for mitochondrial membrane potential in living cells. J. Biomol. Screen. 7, 383-389.
75. Sie, L.T., van der Knaap, M.S., Oosting, J., de Vries, L.S., Lafeber, H.N., Valk, J., 2000. MR patterns of hypoxic-ischemic brain damage after prenatal, perinatal or postnatal asphyxia. Neuropediatrics 31, 128-136. (Pubitemid 30495436)
76. Strata, F., Coq, j.-o., Byl, N., Merzenich, M.M., 2004. Effects of sensorimotor restriction and anoxia on gait and motor cortex organization: implications for a rodent model of cerebral palsy. Neuroscience 129, 141-156.
77. Sunderman, F.W., Marzouk, A., Hopfer, S.M., Zaharia, O., Reid, M.C., 1985. Increased lipid peroxidation in tissues of nickel chloride-treated rats. Ann. Clin. Lab. Sci. 15, 229-236.
78. Suresh, L.M., Namratta, M., Ram, R., 2007. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 54, 34-66.
79. Takaaki, K., 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239, 57-69.
80. Takehiko, I., 2006. Mitochondrial membrane potential and ischemic neuronal death. Neurosci. Res. 55, 234-243.
81. Thomas, F.W.H., Gerald, W., Steven, D., Samuel, W., Gerburg, K., Brian, A.M-V., 2002. Nitric oxide promotes intracellular calcium release from mitochondria in striatal neurons. FASEB J. 16, 1611-1622.
82. Tobaben, S., Grohm, J., Seiler, A., Conrad, M., Plesnila, N., Culmsee, C., 2011. Bidmediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons. Cell Death Differ. 18, 282-292.
83. Tomohiro, H., Koichi, W., Yukiko, U., Hisashi, Y., Yoshihiro, O., 2005. Repetitive transient depolarizations of the inner mitochondrial membrane induced by proton pumping. Biophys. J. 88, 2340-2349.
84. Tomris, O., Esor, B., Sevin, B., Mustafa, S., Saadet, G., 2005. Effects of MK-801 on nitrite and cGMP levels during focal cerebral ischemia in rats. Nitric Oxide 13, 210-215.
85. Uchiyama, M., Mihara, M., 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86, 271-278.
86. Ursula, S., Hong, Q., Michael, A., 2002. Pharmacology and toxicology of astrocyte - neuron glutamate transport and cycling. J. Pharmacol. Exp. Ther. 301, 1-6.
87. Valina, L.D., Ted, M.D., Edythe, D.L., David, S.B., Solomon, H.S., 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U. S. A. 88, 6368-6371.
88. Van-de, B.W.D.J., Blokland, A., Cuello, A.C., Schmitz, C., Vreuls, W., Steinbusch, H.W.M., Blanco, C.E., 2000. Perinatal asphyxia results in changes in presynaptic bouton number in striatum and cerebral cortex-A stereological and behavioral analysis. J. Chem. Neuroanat. 20, 71-82.
89. Vannucci, R.C., Towfighi, J., Vannucci, S.J., 2004. Secondary energy failure after cerebral hypoxia - ischemia in the immature rat. J. Cereb. Blood Flow Metab. 24, 1090-1097.
90. World Health Organization (WHO), 1998. Department of Reproductive Health and Research. Basic Newborn Resuscitation: A Practical Guide. WHO/RHT/MSM/98.1, 32 pp.
91. Xiao-Jian, H., Yun-Fei, Lu., Shun-Ai, L., Kazuhito, T., Kohji, T., Masayuki, M., Hideki, M., 2008. Involvement of calcineurin in glutamate-induced mitochondrial dynamics in neurons. Neurosci. Res. 60, 114-119.
92. Young, J.L., Yueming, H., Hongyu, F., Zhiyi, Z., 2003. Effects of local and intravenous anesthetics on the activity of glutamate transporter type 2. Brain Res. Bull. 61, 537-540.
93. Ze, D.J., Dorothea, M.B., Jin, W., Xiu, X., Guo, Q.C., Xiao, M.S., Andrew, R.W., 2003. Course of brainstem pathophysiology during first month in term infants after perinatal asphyxia, revealed by MLS BAER latencies and intervals. Pediatr. Res. 54, 680-687.
94. Zheng, L., Ken, -I.O., Yasunori, H., Morgan, S., 2004. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873-887.